Megna Michael R 4
4 · Kiniksa Pharmaceuticals International, plc · Filed Oct 8, 2025
Insider Transaction Report
Form 4
Megna Michael R
CHIEF ACCOUNTING OFFICER
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-10-04+175→ 38,186 total - Exercise/Conversion
Restricted Share Unit
2025-10-04−175→ 0 total→ Class A Ordinary Share (175 underlying) - Tax Payment
Class A Ordinary Share
2025-10-04$38.49/sh−85$3,272→ 38,101 total
Footnotes (2)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- [F2]The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021.